What is the recommended workup for chronic generalized musculoskeletal aches?

Workup for Chronic Body Aches

Begin with a comprehensive laboratory panel including ESR, CRP, CBC, comprehensive metabolic panel, and urinalysis to differentiate inflammatory from non-inflammatory causes, then proceed with targeted testing based on clinical features and initial results. 1

Initial Clinical Assessment

Distinguish between localized and generalized pain patterns, as this fundamentally changes the diagnostic approach and differential diagnosis. 2

Key Clinical Features to Document

• Pain characteristics: severity, quality (burning, aching, shooting), distribution (focal vs. widespread), and duration (≥3 months defines chronicity). 3
• Presence of objective weakness: Test proximal muscle strength (shoulder abduction, hip flexion) to separate true myositis from pain-only syndromes like fibromyalgia or polymyalgia rheumatica. 1, 4
• Joint examination: Systematically assess all peripheral joints for swelling, erythema, warmth, and range of motion to identify inflammatory arthritis patterns. 2, 4
• Functional impact: Document disability in activities of daily living, sleep quality, and psychological factors including catastrophizing, fear of movement, and depression. 2
• Medication history: Screen for statins (cause myalgia without weakness) and immune-checkpoint inhibitors (can precipitate severe myositis). 1, 4

Core Laboratory Workup (All Patients)

Order ESR and CRP as first-line inflammatory markers; CRP is slightly more sensitive and specific for acute inflammation. 1

Essential Initial Tests

• Complete blood count: Identifies anemia, leukocytosis, or thrombocytosis accompanying systemic inflammation. 1
• Comprehensive metabolic panel: Including liver enzymes, creatinine, glucose, and urate to detect organ involvement and metabolic mimics. 1
• Urinalysis: Screens for proteinuria (renal involvement) or myoglobinuria (rhabdomyolysis). 1
• Creatine kinase (CK): The single most sensitive marker for muscle inflammation; mandatory when weakness or significant myalgia is present. 1, 4

Critical Safety Point

Never omit cardiac troponin when myositis is suspected—concurrent myocarditis markedly increases mortality and requires immediate intervention. 1, 4

Severity-Based Diagnostic Algorithm

Mild Symptoms (Pain Without Weakness or Functional Limitation)

• Obtain ESR, CRP, CBC, comprehensive metabolic panel, and urinalysis. 1
• If ESR >50 mm/hr, add rheumatoid factor (RF) and anti-CCP antibodies to screen for rheumatoid arthritis. 1
• Consider plain radiographs of symptomatic joints (hands, wrists, feet) if inflammatory arthritis is suspected; erosions predict persistent disease. 1
• Chest radiography to exclude pulmonary involvement, malignancy, or sarcoidosis. 1

Moderate Symptoms (Functional Limitation, Joint Swelling, or Persistent Pain)

Perform all investigations listed for mild disease, plus:

• Full autoimmune panel: ANA, RF, anti-CCP, and extractable nuclear antigen (ENA) panel. 1
• HLA-B27 testing if clinical features suggest reactive arthritis or axial spondyloarthropathy. 1
• Joint imaging (ultrasound or MRI) if synovitis is evident or symptoms persist despite initial therapy. 1
• Refer to rheumatology within 1–2 weeks for specialist evaluation. 1, 4

Severe Symptoms (Objective Weakness, Dysphagia, Dyspnea, or Chest Pain)

These are red-flag features requiring urgent evaluation:

• Immediately order: CK, cardiac troponin, aldolase, LDH, AST, ALT, ESR, CRP, CBC, comprehensive metabolic panel, and urinalysis. 1, 4
• Myositis-specific antibodies: Anti-Jo-1, anti-Mi-2, anti-SRP, anti-TIF1γ, anti-NXP2. 1, 4
• Anti-acetylcholine-receptor antibodies if myasthenia gravis overlap is suspected (the myositis-myasthenia-myocarditis triad has very high mortality). 1, 4
• ECG and consider echocardiography or cardiac MRI if troponin is elevated. 1, 4
• Arrange same-day specialist referral and consider hospital admission for urgent management. 1, 4

Advanced Diagnostic Testing (When Diagnosis Remains Uncertain)

• MRI of proximal muscles: Visualizes inflammation, guides biopsy site selection, and monitors therapeutic response when myositis is suspected. 1, 4
• Electromyography (EMG): Shows fibrillations and polyphasic potentials in myositis; positive predictive value of 0.66 for myopathy. 4
• Muscle biopsy: Provides highest positive predictive value (0.78) for confirming myopathy; recommended when diagnosis remains uncertain or overlap syndromes are suspected. 4

Common Chronic Pain Conditions and Their Diagnostic Features

Fibromyalgia

Characterized by generalized widespread chronic pain (≥3 months) with multiple tender points on examination and normal CK. 3

• Believed to result from central sensitization with inadequate filtering of nociceptive signals. 3
• Key diagnostic feature: Severe pain with normal inflammatory markers and normal muscle enzymes. 1, 4

Polymyalgia Rheumatica

Presents with severe proximal pain and stiffness, markedly elevated ESR/CRP (typically >50 mm/hr), normal CK, and no objective weakness. 4

• Distinguished from myositis by absence of true weakness on formal strength testing. 1, 4

Inflammatory Arthritis (Rheumatoid Arthritis)

• RF and anti-CCP antibodies are strongly predictive of diagnosis and progression; negative results do not rule out RA. 1
• Baseline plain radiographs of hands, wrists, and feet; erosions predict persistent disease. 1

Neuropathic Pain

Presents as continuous or intermittent spontaneous pain, described as burning, aching, or shooting. 3

• Includes diabetic neuropathy, lumbar nerve root compression, and other nerve-related conditions. 3

Critical Pitfalls to Avoid

• A normal CK does not exclude inflammatory disease—conditions like polymyalgia rheumatica and inflammatory arthritis present with severe pain and elevated ESR/CRP despite normal CK. 1, 4
• Distinguish pain-limited movement from true objective weakness by formally testing proximal muscle strength; pain-only syndromes retain normal strength. 1, 4
• Screen for medication-induced myopathy (statins, immune-checkpoint inhibitors) as these can precipitate severe, potentially fatal myositis even months after exposure. 1, 4
• Negative RF and anti-CCP do not rule out progression to rheumatoid arthritis—ongoing clinical follow-up and repeat serology may be required. 1
• Never delay specialist referral when red-flag features are present: objective weakness, dysphagia, dyspnea, chest pain, or markedly elevated CK with troponin elevation. 1, 4

Stepped-Care Treatment Framework

While awaiting diagnostic results, provide education and self-management support as first-line intervention. 2

• Step 1: Education, encouragement to stay active, sleep hygiene guidelines, and online or face-to-face self-management interventions. 2
• Step 2: Physical activity/exercise programs, orthotics if indicated, and specialist referral for targeted treatments. 2
• Step 3: Multidisciplinary treatment including cognitive-behavioral therapy when psychosocial factors (fear of movement, catastrophizing) underlie disability. 2